| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.444 | 1.324 | 1.826 | 1.908 | 1.482 | 1.173 | 2.009 | 2.069 | 2.210 | 1.122 |
| Total Income - EUR | 1.444 | 1.324 | 1.826 | 1.908 | 1.492 | 1.173 | 2.009 | 2.069 | 2.210 | 1.122 |
| Total Expenses - EUR | 1.315 | 1.295 | 1.507 | 1.546 | 1.402 | 1.503 | 1.741 | 2.073 | 1.948 | 1.158 |
| Gross Profit/Loss - EUR | 129 | 29 | 318 | 361 | 90 | -330 | 269 | -4 | 261 | -36 |
| Net Profit/Loss - EUR | 86 | -10 | 264 | 304 | 46 | -366 | 209 | -58 | 220 | -36 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Diagab Cell Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.461 | 2.419 | 2.650 | 2.917 | 2.886 | 2.505 | 2.718 | 2.669 | 2.844 | 2.751 |
| Inventories | 1.896 | 2.148 | 2.171 | 2.316 | 2.271 | 2.225 | 2.176 | 2.183 | 2.176 | 2.164 |
| Receivables | 60 | 59 | 58 | 0 | 0 | 0 | 0 | 0 | 0 | 23 |
| Cash | 506 | 212 | 421 | 601 | 615 | 279 | 541 | 487 | 668 | 565 |
| Shareholders Funds | 2.442 | 2.406 | 2.629 | 2.885 | 2.875 | 2.455 | 2.610 | 2.560 | 2.773 | 2.721 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19 | 18 | 21 | 32 | 11 | 49 | 107 | 109 | 71 | 30 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9529 - 9529" | |||||||||
| CAEN Financial Year |
9529
|
|||||||||
Comments - Diagab Cell Srl